Coloplast A/S (CLPBY)
12.41
+0.36
(+2.99%)
USD |
OTCM |
May 03, 16:00
Coloplast Price to Book Value: 12.42 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 12.42 |
| May 02, 2024 | 12.06 |
| May 01, 2024 | 12.23 |
| April 30, 2024 | 12.20 |
| April 29, 2024 | 12.51 |
| April 26, 2024 | 12.47 |
| April 25, 2024 | 12.59 |
| April 24, 2024 | 13.35 |
| April 23, 2024 | 13.28 |
| April 22, 2024 | 12.96 |
| April 19, 2024 | 12.99 |
| April 18, 2024 | 12.88 |
| April 17, 2024 | 12.98 |
| April 16, 2024 | 13.09 |
| April 15, 2024 | 13.02 |
| April 12, 2024 | 12.99 |
| April 11, 2024 | 13.57 |
| April 10, 2024 | 13.30 |
| April 09, 2024 | 13.33 |
| April 08, 2024 | 13.37 |
| April 05, 2024 | 13.41 |
| April 04, 2024 | 13.33 |
| April 03, 2024 | 13.41 |
| April 02, 2024 | 13.34 |
| April 01, 2024 | 13.61 |
| Date | Value |
|---|---|
| March 28, 2024 | 13.55 |
| March 27, 2024 | 13.57 |
| March 26, 2024 | 13.53 |
| March 25, 2024 | 13.56 |
| March 22, 2024 | 13.52 |
| March 21, 2024 | 13.55 |
| March 20, 2024 | 13.72 |
| March 19, 2024 | 13.49 |
| March 18, 2024 | 13.64 |
| March 15, 2024 | 13.77 |
| March 14, 2024 | 13.72 |
| March 13, 2024 | 14.08 |
| March 12, 2024 | 14.32 |
| March 11, 2024 | 14.19 |
| March 08, 2024 | 14.22 |
| March 07, 2024 | 14.14 |
| March 06, 2024 | 13.81 |
| March 05, 2024 | 13.50 |
| March 04, 2024 | 13.68 |
| March 01, 2024 | 13.44 |
| February 29, 2024 | 13.41 |
| February 28, 2024 | 13.23 |
| February 27, 2024 | 13.46 |
| February 26, 2024 | 13.47 |
| February 23, 2024 | 13.37 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
9.243
Minimum
Oct 19 2023
39.23
Maximum
Aug 03 2020
27.06
Average
27.92
Median
Jul 22 2019
Price to Book Value Benchmarks
| Genmab A/S | 4.088 |
| Ascendis Pharma A/S | -- |
| Galecto Inc | 0.5871 |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | 0.7322 |
Price to Book Value Related Metrics
| PE Ratio | 38.36 |
| PS Ratio | 7.423 |
| PEG Ratio | 7.377 |
| Price to Free Cash Flow | 43.64 |
| Price | 12.41 |
| Earnings Yield | 2.61% |
| Market Cap | 27.90B |
| PEGY Ratio | 5.016 |
| Operating PE Ratio | 26.92 |
| Normalized PE Ratio | 38.48 |